Lin Liu, Danying Liao, Weijiayi Wang, Wei Xie, Jia Xu, Yinqiang Zhang, Fen Zhou, Heng Mei. "Inotuzumab ozogamicin vs blinatumomab bridging optimization and second CD19 CAR-T efficacy in Relapsed/Refractory B-ALL." Blood (2025). https://doi.org/10.1182/blood-2025-2398